|
Gene expression of somatostatin receptor subtypes, SSTR1 and SSTR2, in human lung cancer cell lines
|
04 October 2017 |
|
Growth-inhibitory effects of vitamin D analogues and retinoids on human pancreatic cancer cells
|
03 October 2017 |
|
Treatment of R-3327 prostate tumors with a somatostatin analogue (somatuline) as adjuvant therapy following surgical castration
|
29 September 2017 |
|
Characterization of somatostatin receptors on human neuroblastoma tumors
|
21 September 2017 |
|
Somatostatin in neuroblastoma and ganglioneuroma
|
20 September 2017 |
|
Neuroblastoma. Correlation of neuropeptide expression in tumor tissue with other prognostic factors
|
12 September 2017 |
|
Cloning, functional expression and pharmacological characterization of a fourth (hSSTR4) and a fifth (hSSTR5) human somatostatin receptor subtype
|
06 September 2017 |
|
Somatostatin and the lung
|
01 September 2017 |
|
Novel concept of antisurvival factor (ASF) therapy produces an objective clinical response in four patients with hormone-refractory prostate cancer: case report
|
01 September 2017 |
|
Human cholangiocarcinomas express somatostatin receptors and respond to somatostatin with growth inhibition
|
31 August 2017 |